Christopher Thanos Ph.D., Laura Hix Glickman Ph.D., Amit Kumar Ph.D.
Company Description
Actym Therapeutics has developed a microbial-based immunotherapy platform called STACT (S. Typhimurium Attenuated Cancer Therapy) that specifically enriches in many types of solid tumors and not in healthy tissue, delivering multiplexed immuno-modulatory payloads directly to tumor-resident immune cells.